Evidence map›Paper›PMID 36307008›Full record

ArticleContemporary clinical trials2022

Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancer.

Kelly E Irwin, Catherine A Callaway, Amy E Corveleyn, Catherine R Pappano, Maura J Barry, Keenae M Tiersma, Zoe E Nelson, Lauren E Fields, William F Pirl, Joseph A Greer and 4 more

Open access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. A Positive Distress Screen…Now What? An Updated Call for Integrated Psychosocial Care.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Kelly E IrwinDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Cancer Outcomes Research and Education Program, Massachusetts General Hospital, Boston, MA, United States of America; Mongan Institute of Health Policy, Massachusetts General Hospital, Boston, MA, United States of America. Electronic address: kirwin1@partners.org.
Catherine A CallawayDepartment of Psychology, University of California Berkeley, Berkeley, CA, United States of America.
Amy E CorveleynDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
Catherine R PappanoDepartment of Psychology, University of Colorado Denver, Denver, CO, United States of America.
Maura J BarryUniversity of New England College of Osteopathic Medicine, Biddeford, ME, United States of America.
Keenae M TiersmaUniversity of Washington Medical School, Seattle, WA, United States of America.
Zoe E NelsonDepartment of Psychological Sciences, University of Connecticut, Storrs, CT, United States of America.
Lauren E FieldsDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America.
William F PirlHarvard Medical School, Boston, MA, United States of America; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, United States of America.
Joseph A GreerDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Cancer Outcomes Research and Education Program, Massachusetts General Hospital, Boston, MA, United States of America; Mongan Institute of Health Policy, Massachusetts General Hospital, Boston, MA, United States of America.
Jennifer S TemelHarvard Medical School, Boston, MA, United States of America; Cancer Outcomes Research and Education Program, Massachusetts General Hospital, Boston, MA, United States of America; Mongan Institute of Health Policy, Massachusetts General Hospital, Boston, MA, United States of America; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, United States of America.
David P RyanHarvard Medical School, Boston, MA, United States of America; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, United States of America.
Andrew A NierenbergDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
Elyse R ParkDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Cancer Outcomes Research and Education Program, Massachusetts General Hospital, Boston, MA, United States of America; Mongan Institute of Health Policy, Massachusetts General Hospital, Boston, MA, United States of America.
Harvard University · USMassachusetts General Hospital · USUniversity of California, Berkeley · USUniversity of Colorado Denver · USUniversity of Connecticut · USUniversity of New England · USUniversity of Washington Medical Center · US

Funding

Reducing Disparities in Underserved Patients with Cancer and Serious Mental IllnessK08CA230185 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI IRWIN, KELLY EDWARDS · 2018 to 2022
$1.1M
NCI NIH HHS K08 CA230185
6 · The paper itself

Abstract

backgroundIndividuals with serious mental illness (SMI) experience inequities in cancer care that contribute to increased cancer mortality. Involving mental health at the time of cancer diagnosis may improve cancer care delivery for patients with SMI yet access to care remains challenging. Collaborative care is a promising approach to integrate mental health and cancer care that has not yet been studied in this marginalized population. METHODS/

designWe describe a 24-week, two-arm, single-site randomized trial of person-centered collaborative care (Bridge) for patients with SMI (schizophrenia, bipolar disorder, or major depression with psychiatric hospitalization) and their caregivers. 120 patients are randomized 1:1 to Bridge or Enhanced Usual Care (EUC) along with their caregivers. Researchers proactively identify individuals with SMI and a new breast, lung, gastrointestinal, or head and neck cancer that can be treated with curative intent. EUC includes informing oncologists about the patient's psychiatric diagnosis, notifying patients about available psychosocial services, and tracking patient and caregiver outcomes. Bridge includes a proactive assessment by psychiatry and social work, a person-centered, team approach including collaboration between mental health and oncology, and increased access to evidence-based psycho-oncology care. The primary outcome is cancer care disruptions evaluated by a blinded panel of oncologists. Secondary outcomes include patient and caregiver-reported outcomes and healthcare utilization. Barriers to Bridge implementation and dissemination are assessed using mixed methods. DISCUSSION: This trial will inform efforts to systematically identify individuals with SMI and cancer and generate the first experimental evidence for the impact of person-centered collaborative care on cancer care for this underserved population.

Indexed as

Mental DisordersNeoplasmsOncologistsCaregiversHumansRandomized Controlled Trials as TopicSelf CareCollaborative careHealth equityMental illnessPsycho-oncologySevere mental disorder

Identifiers

PMID36307008
PMCPMC11033617
OpenAlexW4307217078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.